Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joel Charrow

Showing results (41-50 of 110) with videos related to

Pageof 11
Sort By:
American Journal of Medical Genetics. Part A|September 27, 2016
Using a qualitative approach to conceptualize concerns of patients with neurofibromatosis type 1 associated plexiform neurofibromas (pNF) across the lifespanJin-Shei Lai, Sally E Jensen, Zabin S Patel, et al.
Journal of Clinical Psychology in Medical Settings|October 10, 2018
Lifespan Development: Symptoms Experienced by Individuals with Neurofibromatosis Type 1 Associated Plexiform Neurofibromas from Childhood into AdulthoodSally E Jensen, Zabin S Patel, Robert Listernick, et al.
American Journal of Medical Genetics. Part A|May 9, 2024
Aminotransferase trends in propionic acidemiaMaria P Silva, Carolyn R Raski, Joel Charrow, et al.
World Journal for Pediatric & Congenital Heart Surgery|April 15, 2015
Masquerading acidosis after cardiopulmonary bypass: a case of propionic acidemia and congenital heart diseaseRobert A Palermo, Michael C Monge, Joel Charrow, et al.
Nephron|March 30, 2025
Further Clinical and Biochemical Phenotype of GLA p.A143T: A Fabry Disease Newborn Screening ExperienceAllison M Paltzer, Allegra M Quadri, Carly Rasmussen, et al.
Blood|February 19, 2005
Gaucher disease and cancer incidence: a study from the Gaucher RegistryBarry E Rosenbloom, Neal J Weinreb, Ari Zimran, et al.
Molecular Genetics and Metabolism|January 24, 2021
Gaucher disease type 1 patients from the ICGG Gaucher Registry sustain initial clinical improvements during twenty years of imiglucerase treatmentNeal J Weinreb, José Simon Camelo, Joel Charrow, et al.
Methods in Molecular Biology (Clifton, N.J.)|September 20, 2022
Quantification of Branched-Chain Amino Acids in Plasma by High-Performance Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS)Hamed Piri-Moghadam, Alan Miller, Debra Pronger, et al.
Journal of Mass Spectrometry and Advances in the Clinical Lab|May 23, 2022
A rapid LC-MS/MS assay for detection and monitoring of underivatized branched-chain amino acids in maple syrup urine diseaseHamed Piri-Moghadam, Alan Miller, Debra Pronger, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 5, 2022
Long-term effects of eliglustat on skeletal manifestations in clinical trials of patients with Gaucher disease type 1Timothy M Cox, Joel Charrow, Elena Lukina, et al.
Pageof 11

Showing results (41-50 of 110) with videos related to

Sort By:
Pageof 11
American Journal of Medical Genetics. Part A|September 27, 2016
Using a qualitative approach to conceptualize concerns of patients with neurofibromatosis type 1 associated plexiform neurofibromas (pNF) across the lifespanJin-Shei Lai, Sally E Jensen, Zabin S Patel, et al.
Journal of Clinical Psychology in Medical Settings|October 10, 2018
Lifespan Development: Symptoms Experienced by Individuals with Neurofibromatosis Type 1 Associated Plexiform Neurofibromas from Childhood into AdulthoodSally E Jensen, Zabin S Patel, Robert Listernick, et al.
American Journal of Medical Genetics. Part A|May 9, 2024
Aminotransferase trends in propionic acidemiaMaria P Silva, Carolyn R Raski, Joel Charrow, et al.
World Journal for Pediatric & Congenital Heart Surgery|April 15, 2015
Masquerading acidosis after cardiopulmonary bypass: a case of propionic acidemia and congenital heart diseaseRobert A Palermo, Michael C Monge, Joel Charrow, et al.
Nephron|March 30, 2025
Further Clinical and Biochemical Phenotype of GLA p.A143T: A Fabry Disease Newborn Screening ExperienceAllison M Paltzer, Allegra M Quadri, Carly Rasmussen, et al.
Blood|February 19, 2005
Gaucher disease and cancer incidence: a study from the Gaucher RegistryBarry E Rosenbloom, Neal J Weinreb, Ari Zimran, et al.
Molecular Genetics and Metabolism|January 24, 2021
Gaucher disease type 1 patients from the ICGG Gaucher Registry sustain initial clinical improvements during twenty years of imiglucerase treatmentNeal J Weinreb, José Simon Camelo, Joel Charrow, et al.
Methods in Molecular Biology (Clifton, N.J.)|September 20, 2022
Quantification of Branched-Chain Amino Acids in Plasma by High-Performance Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS)Hamed Piri-Moghadam, Alan Miller, Debra Pronger, et al.
Journal of Mass Spectrometry and Advances in the Clinical Lab|May 23, 2022
A rapid LC-MS/MS assay for detection and monitoring of underivatized branched-chain amino acids in maple syrup urine diseaseHamed Piri-Moghadam, Alan Miller, Debra Pronger, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 5, 2022
Long-term effects of eliglustat on skeletal manifestations in clinical trials of patients with Gaucher disease type 1Timothy M Cox, Joel Charrow, Elena Lukina, et al.
Pageof 11